Resultado de búsqueda
James P. Allison (7 de agosto de 1948) es un inmunólogo estadounidense. Ocupa la cátedra de Inmunología y es el director ejecutivo de la plataforma de inmunoterapia en el M. D. Anderson Cancer Center. Sus descubrimientos se orientan hacia nuevos tratamientos para los tipos de cáncer más letales en humanos.
Dr. Allison is a Nobel laureate and a pioneer of immunotherapy for cancer. He is the chair of the Department of Immunology, the director of the Parker Institute for Cancer Immunotherapy, and the executive director of the Immunotherapy Platform at MD Anderson Cancer Center.
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
James P. Allison. The Nobel Prize in Physiology or Medicine 2018. Born: 7 August 1948, Alice, TX, USA. Affiliation at the time of the award: Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
James P. Allison. Biographical. As a basic scientist, I have been fortunate to see my research findings translate into a powerful new potentially curative treatment strategy for cancer. The first patient I met was Sharon Belvin. I met her in 2006 at Memorial Sloan-Kettering Cancer Center (MSKCC).
1 de oct. de 2018 · the 2018 Nobel Prize in Physiology or Medicine. jointly to. James P. Allison and Tasuku Honjo. for their discovery of cancer therapy by inhibition of negative immune regulation. SUMMARY. Cancer kills millions of people every year and is one of humanity’s greatest health challenges.
19 de may. de 2022 · El estadounidense James Patrick Allison (Texas, 1948) es catedrático de Inmunología y director ejecutivo de la Plataforma de Inmunoterapia del M. D. Anderson Cancer Center, Universidad de Texas. El cáncer no lo conoce solo por su trabajo: lo ha padecido él mismo, su madre y su hermano.
